Among these, TP73, XYLB, ALDH4A1, PTPRB, and HLA-DRB5 exhibited high-impact mutations in African American prostate cancer samples, compared to Caucasian white samples Table 2. Here, HLA-DRB5 is linked to prostate carcinoma.